The boxing world is holding its breath as Janibek Alimkhanuly’s career hangs in the balance. But here's where it gets controversial: the undefeated middleweight champion is fighting to clear his name after a positive drug test threatened to derail his reign. Will he emerge victorious, or will his legacy be tarnished? Let’s dive into the details.
Janibek Alimkhanuly’s unified middleweight championship has carried over into the new year, but its future remains uncertain. The ultimate fate of his titles hinges on the outcome of an ongoing investigation into a failed drug test. And this is the part most people miss: the process is far from over, with Alimkhanuly and his team set to observe the unsealing and testing of his B-sample on January 8. This crucial step will determine the next phase of the investigation and, potentially, Alimkhanuly’s career.
For those unfamiliar, the B-sample is a secondary portion of the original test, retained specifically for such situations. While it’s rare for B-sample results to differ from the initial findings, it’s not unheard of. Here’s where it gets even more intriguing: in some cases, boxers have been exonerated by proving contamination or procedural errors in the sample collection process. Could this be Alimkhanuly’s path to redemption?
The Kazakh star, boasting a pristine 17-0 record with 12 knockouts, was slated to face WBA middleweight champion Erislandy Lara in a highly anticipated three-belt unification bout on December 6 in San Antonio. However, those plans were abruptly halted when a November 15 random drug test, conducted by the Voluntary Anti-Doping Association (VADA), detected the banned substance meldonium in his system.
Lara, a seasoned veteran with a 32-3-3 record and 19 knockouts, was left without an opponent but quickly pivoted to face Venezuela’s Johan Gonzalez on short notice. Lara dominated the 12-round bout, securing a unanimous decision on the Isaac Cruz-Lamont Roach undercard.
Meanwhile, Alimkhanuly has been sidelined since his April 5 title defense in Astana, Kazakhstan. He remains under indefinite suspension, his career in limbo as the investigation unfolds. Like many boxers in similar situations, Alimkhanuly has vehemently proclaimed his innocence, expressing shock and confusion over the positive test.
‘I have always supported clean sport,’ Alimkhanuly stated on social media. ‘I was surprised when I read the news. VADA’s first test came back clean, and I haven’t changed my vitamin regimen. I don’t know what happened with the second test, so I requested a retest.’
This isn’t just about one fight or one title—Alimkhanuly’s entire legacy is at stake. His IBF and WBO middleweight titles, along with his reputation as an undefeated champion, could be stripped if he fails to clear his name. Adding to the drama, a potential suspension looms if wrongdoing is proven.
Alimkhanuly’s rise to the top has been nothing short of impressive. He first claimed the interim WBO middleweight title in May 2022, later being elevated to full champion. Since then, he’s successfully defended his titles five times, including three defenses of the IBF belt he won in a stunning October 2023 knockout victory over the previously unbeaten Vincenzo Gualtieri.
As the boxing community awaits the B-sample results, questions linger. Was this an honest mistake, a case of contamination, or something more deliberate? Here’s a thought-provoking question for you: In an era where doping scandals are all too common, how should we balance fairness with the presumption of innocence? Should Alimkhanuly be given the benefit of the doubt, or is the positive test enough to cast doubt on his achievements?
One thing is certain: the outcome of this investigation will send ripples through the boxing world. For now, Alimkhanuly’s fate rests in the hands of those scrutinizing the evidence. Will he emerge as a wronged champion, or will his reign come to an abrupt end? Only time will tell. Share your thoughts in the comments—do you believe Alimkhanuly’s claims of innocence, or is there more to this story than meets the eye?
